Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 72162-2515

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
This data shows the percentage reduction in CPS (Complex Partial Seizures) rate when using Divalproex Sodium Delayed-Release Tablets compared to a placebo. The figure indicates the improvement, no change, and worsening seen in a group of patients.*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
This text is not readable.*
FDA Label Image

Figure-3 (Divalproex Fig3)

Figure-3 (Divalproex Fig3)
FDA Label Image

Structure (Divalproex Str)

Structure (Divalproex Str)
FDA Label Image

Label (Lbl721622515)

Label (Lbl721622515)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.